2023 annual financial data
Context Therapeutics 2023 Operating margin
Context Therapeutics 2023 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -25,072,616 USD and net income was -23,964,211 USD.
Operating cash flow was -21,047,618 USD.
Get free Context Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -25,072,616 USD
- Net income
- -23,964,211 USD
- Operating cash flow
- -21,047,618 USD